Chemical Compound

Daclatasvir

CAS Registry Number 1009119-64-5
Daclatasvir chemical structure
Primary Record

Daclatasvir

In stock
2,263 g
Purity
98.4 %
CAS
1009119-64-5

Compound Identifiers & Properties

CAS
1009119-64-5
PubChem CID
25154714
SMILES
CC(C)[C@@H](C(=O)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
Canonical SMILES
COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C

Names & Synonyms

  • Daclatasvir
  • 1009119-64-5
  • Daklinza
  • BMS-790052
  • Daclatasvir (BMS-790052)
  • daclatasivr
  • daclatasvirum
  • daclatasvir HCl
  • -2-yl)carbamate
  • Daclatasvir [USAN]
  • Daclatasvir (USAN)
  • Daclatasvir dihydrochloride
  • EBP 883
  • daclatasvir hydrochloride
  • BMS790052
  • DACLATASVIR [MI]
  • RefChem:585147
  • DACLATASVIR [INN]
  • BMS 790052
  • Daclatasvir [USAN:INN]
  • cc-39
  • D09SGV
  • EBP-883
  • LI2427F9CI
  • UNII-LI2427F9CI
  • Daclatasvir BMS 790052
  • DACLATASVIR [WHO-DD]
  • 1214735-16-6
  • CHEBI:82977
  • MLS006011140
  • BMS-790052 dihydrochloride
  • MFCD18074519
  • C40H50N8O6
  • DTXSID901026404
  • EBP883
  • orb1300958
  • SCHEMBL2756027
  • CHEMBL2023898
  • SCHEMBL17897804
  • GTPL11266
  • KS-00000XPC
  • EX-A410
  • J05AP07
  • Daclatasvir for system suitability
  • BDBM627982
  • Daclatasvir for peak identification
  • DTXCID901510617
  • GLXC-90030
  • AMY36655
  • AOB87747
  • Daclatasvir, 1214735-16-6
  • 3503AH
  • ABP000738
  • BDBM50387084
  • EBC-27445
  • MFCD17129086
  • s1482
  • ZINC68204830
  • AKOS030524262
  • ACN-050889
  • CA10002
  • CCG-270425
  • CS-0588
  • DB09102
  • RL00957
  • BMS-790052/
  • CVD-0019437
  • NCGC00346533-07
  • NCGC00346533-09
  • NCGC00346533-14
  • AC-28958
  • AS-75298
  • BC638780
  • BMS 790052; EBP 883
  • FD158832
  • HY-10466
  • SMR004702917
  • SY069672
  • BMS-790052-05
  • Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester
  • A3257
  • A5618
  • FT-0771596
  • FT-0772670
  • NS00072904
  • SW219754-1
  • X7549
  • J2.827.385A
  • methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
  • A10159
  • D10065
  • Q-4025
  • A897299
  • EN300-27736661
  • Q5207712
  • BRD-K82861010-001-02-5
  • dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate
  • methyl N-[(2S)-1-[(2S)-2-[5-(4'-{2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl}-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
  • Carbamic acid, N,N'-((1,1'-biphenyl)-4,4'-diylbis(1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,C'-dimethyl ester
  • Daclatasvir, 99%, Highly selective HCV NS5A inhibitors - 25MG 25mg
  • Dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dica
  • methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
  • methyl N-[(1S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate
  • [(Biphenyl-4,4 -diyl)bis[(1H-imidazole-5,2-diyl)(pyrrolidine-2alpha,1-diyl)[(S)-1-oxo-2-isopropylethylene]]]bis(carbamic acid methyl) ester
  • [(Biphenyl-4,4 -diyl)bis[(1H-imidazole-5,2-diyl)[(2S)-pyrrolidine-2,1-diyl][(S)-1-oxo-2-isopropylethylene]]]bis(carbamic acid methyl) ester
  • 1009119-65-6
  • 4,4 -Bis[2-[(2S)-1-[(S)-2-[(methoxycarbonyl)amino]-3-methylbutyryl]pyrrolidine-2-yl]-1H-imidazole-5-yl]-1,1 -biphenyl
  • 5-Pyrimidinecarbonitrile, 4-[[[(3R,5S)-4-[[(trans-4-hydroxycyclohexyl)methyl]amino]tricyclo[3.3.1.13,7]dec-1-yl]methyl]amino]-2-[[[2-(methylthio)-3-pyridinyl]methyl]amino]-, rel-
  • 881-759-2
  • Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, C,C'-dimethyl ester; BMS 790052; Daclatasvir; Daklinza; EBP 883
  • DCV
  • Dimethyl ((2S,2'S)-((2S,2'S)-([1,1'-biphenyl]-4,4'-diylbis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-1,2-diyl))dicarbamate
  • dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(5,5'-([1,1'-biphenyl]-4,4'-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate
  • DIMETHYL N,N'-((1,1'-BIPHENYL)-4,4'-DIYLBIS(1H-IMIDAZOLE-5,2-DIYL-((2S)-PYRROLIDINE-2,1-DIYL)((1S)-3-METHYL-1-OXOBUTANE-1,2-DIYL)))DICARBAMATE
  • Dimethyl N,N'-(biphenyl-4,4'-diylbis(1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1-diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)))dicarbamate
  • Dimethyl N,N'-(biphenyl-4,4'-diylbis{1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)})dicarbamate
  • methyl ((S)-1-((S)-2-(4-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-4-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan
  • methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbama
  • methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamat
  • methyl [(2s)-1-{(2s)-2-[4-(4'-{2-[(2s)-1-{(2s)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1h-imidazol-4-yl}-4-biphenylyl)-1h-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]carbamate
  • methyl [(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate
  • Methyl [(2S)-1-{(2S)-2-[5-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-5-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate
  • methyl N-((2S)-1-((2S)-2-(5-(4-(4-(2-((2S)-1-((2S)-2-(methoxycarbonylamino)-3-methylbutanoyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)phenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
  • methyl N-[(2S)-1-[(2S)-2-[4-(4'-{2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-4-yl}-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
  • methyl-N-[(2s)-1-[(2s)-2-[5-[4-[4-[2-[(2s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl] pyrrolidin-2-yl]-1h-imidazol-5-yl]phenyl]phenyl]-1himidazol-2-yl]pyrrolidin-1-yl]3-methyl-1-oxobutan-2-yl]carbamate
  • N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester
  • TE